SCHEMBL22290974

SCHEMBL22290974

Cc1ncoc1B(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4273507 0.67
SCHEMBL428605 0.66
SCHEMBL26114664 0.66
SCHEMBL8021753 0.66 IMPDH2 (0.39)
SCHEMBL17725133 0.65
SCHEMBL8616571 0.62 KMT2A (0.50)
SCHEMBL4103523 0.62
SCHEMBL5051720 0.62
SCHEMBL13654073 0.62
SCHEMBL22606280 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078131-A1 PYRROLO-PYRIDAZINE INHIBITORS OF JAK2 AJAX THERAPEUTICS INC (US) 2026-03-19 US disclosed
EP-3917925-B1 PYRAZOLOPYRIDINES AND TRIAZOLOPYRIDINES AS A2A / A2B INHIBITORS INCYTE CORP (US) 2024-03-13 EP disclosed
US-11884665-B2 Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors INCYTE CORPORATION (US) 2024-01-30 US disclosed
US-20230033393-A1 PYRAZOLOPYRIDINES AND TRIAZOLOPYRIDINES AS A2A / A2B INHIBITORS INCYTE CORPORATION 2023-02-02 US disclosed
US-11390624-B2 Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors INCYTE CORPORATION (US) 2022-07-19 US disclosed
CN-113906022-A Pyrazolopyridines and triazolopyridines as A2A/A2B inhibitors 因赛特公司 2022-01-07 CN disclosed
EP-3917925-A1 PYRAZOLOPYRIDINES AND TRIAZOLOPYRIDINES AS A2A / A2B INHIBITORS Incyte Corporation (US) 2021-12-08 EP disclosed
US-20200270244-A1 PYRAZOLOPYRIDINES AND TRIAZOLOPYRIDINES AS A2A / A2B INHIBITORS INCYTE CORPORATION 2020-08-27 US disclosed
WO-2020159905-A1 PYRAZOLOPYRIDINES AND TRIAZOLOPYRIDINES AS A2A / A2B INHIBITORS INCYTE CORPORATION (US) 2020-08-06 WO disclosed